azilsartan
Commercial- Indications
- Cardiovascular disease
Company intelligence / Profile preview
Auro Pharma
Hyderabad, Telangana, Indiaauropharma.ca ↗
- Ownership
- Private
- Employees
- ~8797
- Development stage
- Commercial
01
Overview
Aurobindo Pharma is a multinational pharmaceutical company with 870+ marketed drugs and 30+ pipeline drugs. Recent regulatory approvals include Allopurinol Tablets USP and observations from the FDA for its Raleigh plant in April 2025
- Therapeutic areas
- PulmonologyOncologyEndocrinologyImmunologyDermatologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculesgenericsactive pharmaceutical ingredients (APIs)injectablesbiosimilarspeptides
- Industry
- Pharma
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Beyond the preview
Go deeper on Auro Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Auro Pharma.